PROM1 and neoplasm: Initially considered a marker of hematopoietic stem cells, CD133/prominin is a glycosylated trans-membrane protein expressed in various solid tumors, including breast cancer, in which CD133-positivity seems to identify a restricted subgroup of tumor progenitors [23,24].